Understanding the Bone Mass Measurement Act.
The Bone Mass Measurement Act (BMMA) set forth regulations to provide for uniform coverage under Medicare Part B for bone mass measurements for services provided on or after July 1, 1998. The BMMA authorizes Medicare coverage of "medically necessary approved measurements" performed for a "qualified individual" who falls into at least one of five diagnostic categories: an estrogen-deficient woman at clinical risk for osteoporosis; an individual with vertebral abnormalities; an individual receiving long-term glucocorticoid (steroid) therapy; an individual with primary hyperparathyroidism; and an individual being monitored to assess the response to, or efficacy of, an approved osteoporosis drug therapy. Proper communication is essential for reimbursement. The tools for communication include Physician's Current Procedural Terminology (CPT), HCFA (Health Care Financing Administration) Common Procedure Coding System (HCPCS), the Medicare carrier's local Medical Review Policy (LMRP), and the International Classification of Diseases, ninth revision (ICD-9). This article reviews the new regulations and the tools for communication.
Watts
N B
NB
Emory University, Atlanta, GA, USA. nwatts@emory.edu
D015502:Absorptiometry, Photon; D015519:Bone Density; D005260:Female; D006801:Humans; D019458:Insurance Coverage / Q000331:legislation & jurisprudence*; D007349:Insurance, Health, Reimbursement; D016345:Medicare Part B / Q000331:legislation & jurisprudence*; D012307:Risk Factors; D014481:United States